CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJMOriginal Article from The New England Journal of Medicine — CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaCRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM